These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9444951)

  • 1. The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints.
    Thompson DA; Belinsky G; Chang TH; Jones DL; Schlegel R; Münger K
    Oncogene; 1997 Dec; 15(25):3025-35. PubMed ID: 9444951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability.
    Duensing S; Münger K
    Cancer Res; 2002 Dec; 62(23):7075-82. PubMed ID: 12460929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down regulation of p53 with HPV E6 delays and modifies cell death in oxidant response of human diploid fibroblasts: an apoptosis-like cell death associated with mitosis.
    Chen QM; Merrett JB; Dilley T; Purdom S
    Oncogene; 2002 Aug; 21(34):5313-24. PubMed ID: 12149652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression and activity of mitotic regulatory proteins in human papillomavirus-immortalized keratinocytes.
    Steinmann KE; Pei XF; Stöppler H; Schlegel R; Schlegel R
    Oncogene; 1994 Feb; 9(2):387-94. PubMed ID: 8290252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
    Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
    Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
    Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation.
    Liu Y; McKalip A; Herman B
    J Cell Biochem; 2000 May; 78(2):334-49. PubMed ID: 10842327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53-independent abrogation of a postmitotic checkpoint contributes to human papillomavirus E6-induced polyploidy.
    Liu Y; Heilman SA; Illanes D; Sluder G; Chen JJ
    Cancer Res; 2007 Mar; 67(6):2603-10. PubMed ID: 17363579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes.
    Liu X; Han S; Baluda MA; Park NH
    Oncogene; 1997 May; 14(19):2347-53. PubMed ID: 9178911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disregulation of mitotic checkpoints and regulatory proteins following acute expression of SV40 large T antigen in diploid human cells.
    Chang TH; Ray FA; Thompson DA; Schlegel R
    Oncogene; 1997 May; 14(20):2383-93. PubMed ID: 9188853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha.
    Iglesias M; Yen K; Gaiotti D; Hildesheim A; Stoler MH; Woodworth CD
    Oncogene; 1998 Sep; 17(10):1195-205. PubMed ID: 9771962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch1 can contribute to viral-induced transformation of primary human keratinocytes.
    Lathion S; Schaper J; Beard P; Raj K
    Cancer Res; 2003 Dec; 63(24):8687-94. PubMed ID: 14695182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint.
    Thomas JT; Laimins LA
    J Virol; 1998 Feb; 72(2):1131-7. PubMed ID: 9445009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors.
    Toussaint-Smith E; Donner DB; Roman A
    Oncogene; 2004 Apr; 23(17):2988-95. PubMed ID: 14968115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis.
    Stöppler H; Stöppler MC; Johnson E; Simbulan-Rosenthal CM; Smulson ME; Iyer S; Rosenthal DS; Schlegel R
    Oncogene; 1998 Sep; 17(10):1207-14. PubMed ID: 9771963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
    Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV 16-E6-mediated degradation of intrinsic p53 is compensated by upregulation of p53 gene expression in normal cervical keratinocytes.
    Kawamata Y; Mitsuhashi A; Unno Y; Kado S; Shino Y; Uesugi K; Eguchi O; Ishii J; Seki K; Sekiya S; Shirasawa H
    Int J Oncol; 2002 Sep; 21(3):561-7. PubMed ID: 12168100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
    Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV-16 E6 oncoprotein impairs the fidelity of DNA end-joining via p53-dependent and -independent pathways.
    Shin KH; Ahn JH; Kang MK; Lim PK; Yip FK; Baluda MA; Park NH
    Int J Oncol; 2006 Jan; 28(1):209-15. PubMed ID: 16327998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.